Saudi Arabia Veterinary Vaccine Market Introduction and Overview
According to SPER Market Research, the Saudi Arabia Veterinary Vaccine Market is estimated to reach USD 0.53 billion by 2033 with a CAGR of 8.91%.
The report includes an in-depth analysis of the Saudi Arabia Veterinary Vaccine Market, including market size and trends, product mix, Route of Administrations, and supplier analysis. Vaccines for animals are crucial instruments for preventing and controlling infectious illnesses in animals. They shield animals from numerous diseases, such as viruses and bacteria, by triggering an immunological response. These vaccinations are essential for maintaining animal health, minimising disease transmission to people, and guaranteeing the safety of food. Specific species and local disease risks are taken into account while designing vaccination programmes. Veterinary vaccines, which are frequently given to livestock, pets, and wildlife, are essential for protecting animal populations, supporting sustainable agriculture, and advancing public health. The efficiency of vaccines is always being improved, and their applications are growing because to ongoing research and technological breakthroughs.
- The market has been introduced to Bovilis Nasalgen 3-PMH by Merck & Co. The Bovilis ® Nasalgen ® 3-PMH vaccine, the first and only intranasal BRD vaccine, offers defence against BRSV, IBR, PI3, Mannheimia haemolytica, and Pasteurella multocida. Use of this bovine vaccination in young, healthy calves is safe.
- "Elanco Mater Guard" is a brand-new product from Elanco Animal Health Incorporated. The respiratory and reproductive systems of cattle, particularly those of pregnant cows, are safeguarded by this special mixture of MLV and antigens. Cows can receive these vaccinations at any stage of pregnancy.
Market Opportunities and Challenges
- Opportunities: The growing emphasis on animal health, livestock management, and food security will lead to an increase in the market for veterinary vaccines in Saudi Arabia. Animal infections can be prevented and controlled with the use of veterinary vaccines, protecting livestock health and productivity. The demand for efficient veterinary vaccinations is anticipated to increase as a result of the nation's initiatives to improve animal welfare, promote livestock output, and guarantee food safety. Government programmes and rules pertaining to animal health also aid in the market's progress.
- Challenges: The Saudi Arabian market for veterinary vaccines confronts difficulties with regard to regulatory compliance, illness surveillance, and vaccination effectiveness. To protect animal health, it is essential to ensure that veterinary vaccinations adhere to high regulatory criteria for safety and efficacy. To uncover new dangers and provide efficient vaccinations, disease surveillance and precise diagnosis are also crucial. To provide vaccines that effectively prevent and manage diseases in a variety of animal species, manufacturers must stay up to date on the most recent research and work in collaboration with veterinary specialists.
Market Competitive Landscape
The market exhibits a moderate level of fragmentation, with several major players, including Bayer AG, Boehringer Ingelheim International GmbH, Ceva, GSK plc, Merck & Co., Inc., Pfizer Inc., Sanofi, Takeda Pharmaceutical Company Limited, Zoetis, Others. To further solidify their position in the Saudi Arabian veterinary vaccines market, these firms employ a variety of methods, such as increasing investments in their R&D operations, mergers and acquisitions, joint ventures, partnerships, licencing agreements, and the launching of new products and services.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Type, By Technology, By Route of Administration
|
| Regions covered | Eastern, Central, Northern, Northwest, Midwest, and Southwest Saudi Arabia
|
| Companies Covered | Bayer AG, Boehringer Ingelheim International GmbH, Ceva, GSK plc, Merck & Co., Inc., Pfizer Inc., Sanofi, Takeda Pharmaceutical Company Limited, Zoetis, Others
|
COVID-19 Impact on Saudi Arabia Veterinary Vaccine Market
The Saudi Arabian veterinary vaccinations market was greatly influenced by the COVID-19 epidemic. The demand for vaccines and other animal healthcare items fluctuated while restrictions and economic uncertainty persisted. Veterinary clinics had decreased foot traffic due to restrictions on travel and gatherings, which had an impact on vaccine administration. Disruptions in supply systems also made it difficult to access and distribute immunisations. But after the pandemic passed, the market began to slowly rebound as economic activity picked back up and people's awareness of animal health rose. How the country handles a potential reappearance of the virus and maintains its economic recovery will determine the long-term impact.
Key Target Audience:
- Animal Health Organizations
- Animal Rescue Organizations
- Livestock Producers
- Media and Public Health Communicators
- Pet Owners
- Pet Retailers
- Pharmaceutical Companies
- Veterinarians
- Veterinary Technicians and Nurses
- Zoo and Wildlife Veterinarians
- Others
Our in-depth analysis of the Saudi Arabia Veterinary Vaccine Market includes the following segments:
|
By Type:
|
Companion Animal Vaccines
Livestock Vaccines
|
|
By Payload Capacity:
|
Inactivated Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Toxoid Vaccines
|
|
By Route of Administration:
|
Injectable Vaccines
Intranasal
|
Key Topics Covered in the Report:
- Saudi Arabia Veterinary Vaccine Market Size (FY’2023-FY’2033)
- Overview of Saudi Arabia Veterinary Vaccine Market
- Segmentation of Saudi Arabia Veterinary Vaccine Market By Type (Companion Animal Vaccines, Livestock Vaccines)
- Segmentation of Saudi Arabia Veterinary Vaccine Market By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Others)
- Segmentation of Saudi Arabia Veterinary Vaccine Market By Route of Administration (Injectable Vaccines, Intranasal, Others)
- Statistical Snap of Saudi Arabia Veterinary Vaccine Market
- Expansion Analysis of Saudi Arabia Veterinary Vaccine Market
- Problems and Obstacles in Saudi Arabia Veterinary Vaccine Market
- Competitive Landscape in the Saudi Arabia Veterinary Vaccine Market
- Impact of COVID-19 and Demonetization on Saudi Arabia Veterinary Vaccine Market
- Details on Current Investment in Saudi Arabia Veterinary Vaccine Market
- Competitive Analysis of Saudi Arabia Veterinary Vaccine Market
- Prominent Players in the Saudi Arabia Veterinary Vaccine Market
- SWOT Analysis of Saudi Arabia Veterinary Vaccine Market
- Saudi Arabia Veterinary Vaccine Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Saudi Arabia Veterinary Vaccine Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Saudi Arabia Veterinary Vaccine Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Saudi Arabia Veterinary Vaccine Market
7. Saudi Arabia Veterinary Vaccine Market, By Type (USD Million)
7.1. Saudi Arabia Veterinary Vaccine Market Value Share and Forecast, By Type, 2023-2033
7.2. Companion Animal Vaccines
7.2.1. Canine Vaccines
7.2.2. Equine Vaccines
7.2.3. Feline Vaccines
7.3. Livestock Vaccines
7.3.1. Bovine Vaccines
7.3.2. Poultry Vaccines
7.3.3. Others
8. Saudi Arabia Veterinary Vaccine Market, By Technology (USD Million)
8.1. Saudi Arabia Veterinary Vaccine Market Value Share and Forecast, By Technology, 2023-2033
8.2. Inactivated Vaccines
8.3. Live Attenuated Vaccines
8.4. Recombinant Vaccines
8.5. Toxoid Vaccines
8.6. Others
9. Saudi Arabia Veterinary Vaccine Market, By Route of Administration (USD Million)
9.1. Saudi Arabia Veterinary Vaccine Market Value Share and Forecast, By Route of Administration, 2023-2033
9.2. Injectable Vaccines
9.3. Intranasal
9.4. Others
10. Saudi Arabia Veterinary Vaccine Market Forecast, 2019-2033 (USD Million)
10.1. Saudi Arabia Veterinary Vaccine Market Size and Market Share
11. Saudi Arabia Veterinary Vaccine Market, By Type, 2019-2033 (USD Million)
11.1. Saudi Arabia Veterinary Vaccine Market Size and Market Share By Type (2019-2026)
11.2. Saudi Arabia Veterinary Vaccine Market Size and Market Share By Type (2027-2033)
12. Saudi Arabia Veterinary Vaccine Market, By Technology, 2019-2033 (USD Million)
12.1. Saudi Arabia Veterinary Vaccine Market Size and Market Share By Technology (2019-2026)
12.2. Saudi Arabia Veterinary Vaccine Market Size and Market Share By Technology (2027-2033)
13. Saudi Arabia Veterinary Vaccine Market, By Route of Administration, 2019-2033 (USD Million)
13.1. Saudi Arabia Veterinary Vaccine Market Size and Market Share By Route of Administration (2019-2026)
13.2. Saudi Arabia Veterinary Vaccine Market Size and Market Share By Route of Administration (2027-2033)
14. Saudi Arabia Veterinary Vaccine Market, By Region, 2019-2033 (USD Million)
14.1. Saudi Arabia Veterinary Vaccine Market Size and Market Share By Region (2019-2026)
14.2. Saudi Arabia Veterinary Vaccine Market Size and Market Share By Region (2027-2033)
14.3. Eastern
14.4. Central
14.5. Northern
14.6. Northwest
14.7. Midwest
14.8. Southwest
15. Company Profile
15.1. Bayer AG
15.1.1. Company details
15.1.2. Financial outlook
15.1.3. Product summary
15.1.4. Recent developments
15.2. Boehringer Ingelheim International GmbH
15.2.1. Company details
15.2.2. Financial outlook
15.2.3. Product summary
15.2.4. Recent developments
15.3. Ceva
15.3.1. Company details
15.3.2. Financial outlook
15.3.3. Product summary
15.3.4. Recent developments
15.4. GSK plc
15.4.1. Company details
15.4.2. Financial outlook
15.4.3. Product summary
15.4.4. Recent developments
15.5. Merck & Co., Inc.
15.5.1. Company details
15.5.2. Financial outlook
15.5.3. Product summary
15.5.4. Recent developments
15.6. Pfizer Inc.
15.6.1. Company details
15.6.2. Financial outlook
15.6.3. Product summary
15.6.4. Recent developments
15.7. Sanofi
15.7.1. Company details
15.7.2. Financial outlook
15.7.3. Product summary
15.7.4. Recent developments
15.8. Takeda Pharmaceutical Company Limited
15.8.1. Company details
15.8.2. Financial outlook
15.8.3. Product summary
15.8.4. Recent developments
15.9. Zoetis
15.9.1. Company details
15.9.2. Financial outlook
15.9.3. Product summary
15.9.4. Recent developments
15.10. Others
16. List of Abbreviations
17. Reference Links
18. Conclusion
19. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
